48 min listen
SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
SPECIAL REPORT on Aducanumab Approval: Discussion with Cognitive Behavioral Neurologists
ratings:
Length:
12 minutes
Released:
Jun 19, 2021
Format:
Podcast episode
Description
Dr. Jeff Burns, Director of the University of Kansas Alzheimer’s Disease Center, speaks with Dr. Ron Petersen, Director of the Mayo Clinic Alzheimer's Disease Center, about the recent FDA approval of aducanumab for the treatment of Alzheimer disease.
Released:
Jun 19, 2021
Format:
Podcast episode
Titles in the series (100)
December 4 2007 Issue: A structural basis for reading fluency: White matter detects in a genetic brain malformation by Neurology® Podcast